Back to results

CompletedPhase 2

A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

NCT00880412

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hôpital Privé Les Magnolias

Ballainvilliers, France

+21 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-04
Enrollment: 197 participants
Sponsor: Exonhit
Purpose: treatment

Locations (22)

Hôpital Privé Les MagnoliasBallainvilliers, France
Cabinet MédicalBergerac, France
Fleyriat HospitalBourg-en-Bresse, France
Cabinet MédicalDijon, France
Charles Foix HospitalIvry-sur-Seine, France
Cabinet MédicalLa Seyne-sur-Mer, France
Roger Salengro HospitalLille, France
Dupuytren HospitalLimoges, France
Clinique Léopold BellanMagnanville, France
Cabinet MédicalMontpellier, France
Cabinet Médical 2Montpellier, France
CHU Nantes Hôpital LaennecNantes, France
Cabinet Médical 2Nice, France
Cabinet MédicalNice, France
CHU Cochin BrocaParis, France
Cabinet MédicalRambouillet, France
CHU RennesRennes, France
Cabinet MédicalRodez, France
Cabinet MédicalRueil-Malmaison, France
Cabinet MédicalSaint-Brieuc, France
Cabinet MédicalToulon, France
Purpan-Casselardit Hospital - University of ToulouseToulouse, France